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Abstract
Background: Creatine supplementation can improve performance during high intensity exercise in humans and improve
muscle strength in certain myopathies. In this present study, we investigated the direct effects of acute creatine incubation
on isolated mouse fast-twitch EDL muscles, and examined how these effects change with fatigue.
Methods and Results: The extensor digitorum longus muscle from mice aged 12–14 weeks was isolated and stimulated with
field electrodes to measure force characteristics in 3 different states: (i) before fatigue; (ii) immediately after a fatigue
protocol; and (iii) after recovery. These served as the control measurements for the muscle. The muscle was then incubated
in a creatine solution and washed. The measurement of force characteristics in the 3 different states was then repeated. In
un-fatigued muscle, creatine incubation increased the maximal tetanic force. In fatigued muscle, creatine treatment
increased the force produced at all frequencies of stimulation. Incubation also increased the rate of twitch relaxation and
twitch contraction in fatigued muscle. During repetitive fatiguing stimulation, creatine-treated muscles took 55.169.5%
longer than control muscles to lose half of their original force. Measurement of weight changes showed that creatine
incubation increased EDL muscle mass by 7%.
Conclusion: Acute creatine application improves force production in isolated fast-twitch EDL muscle, and these
improvements are particularly apparent when the muscle is fatigued. One likely mechanism for this improvement is an
increase in Ca
2+ sensitivity of contractile proteins as a result of ionic strength decreases following creatine incubation.
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Introduction
The ingestion of supplementary creatine can increase intra-
muscular creatine and improve performance, particularly during
maximally fatiguing exercise [1,2]. It can also enhance muscle
strength in certain myopathies, such as muscular dystrophy [3].
Creatine cannot be synthesized in skeletal muscle cells and is
transported into skeletal muscle by a Na
+-dependent transmem-
brane protein [4]. The creatine(Cr)/phosphocreatine(PCr) cycle
acts as a temporal buffer of ATP during the first seconds of intense
skeletal muscle contraction before glycolysis and mitochondrial
mechanisms can respond to the increased demand for ATP.
Without this buffering most skeletal muscles would run out of ATP
after less than one second of intense exercise [5]. The Cr/PCr
cycle is also an important source and transporter of ATP during
the later stages of prolonged muscle activity. The Cr/PCr cycle is
catalyzed by creatine kinase (CK), which has two main isoforms in
skeletal muscle. Firstly, Mi-CK, the mitochondrial isoform [6], is
bound to the inner membrane of the mitochondria [7] and is
functionally linked to oxidative phosphorylation [8]. Secondly,
MM-CK, the M-line isoform, is localised to the M-line of the
A-band of the contractile apparatus and is functionally coupled to
glycolysis [9]. This means that myosin ATPase preferentially uses
ATP supplied by CK rather than cytosolic ATP [10]. This
arrangement enables the Cr/PCr system to also function as a
‘‘spatial energy buffer’’ termed the ‘‘Creatine Phosphate Shuttle’’
[10,11]. PCr and Cr ‘‘shuttle’’ molecules between the sites of ATP
production and utilisation with several significant advantages. PCr
and Cr have higher diffusion rates than ATP or ADP and
therefore are more efficient as energy shuttles [12]. At the
sarcomeres, where large amounts of ATP are hydrolyzed during
repetitive contractions, the MM-CK allows for the immediate
phosphorylation of ADP. This maintains a low ADP concentra-
tion, thus reducing the ADP-mediated leak of Ca
2+ from the SR,
which would reduce the releasable Ca
2+ and hence reduce the
force output of the muscle [13]. It also reduces the free inorganic
phosphate (Pi), slowing the entry of Pi into the SR where it
precipitates the Ca
2+ to cause a failure of Ca
2+ release, reducing
the force produced by the muscle [14–16]. Conversely, phosphor-
ylation of Cr by Mi-CK keeps mitochondrial levels of ADP high,
which stimulates the respiration rate and reduces the free energy
required for ATP synthesis [8]. Mice which lack the MM-CK
isoform of creatine kinase have been developed and display an
inability to sustain maximal muscle force output during high
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the MM-CK-deficient mice [18]. Injection of small amounts of
creatine into skeletal muscle deficient in all isoforms of creatine
kinase restored its fatigue characteristics to wild-type specifications
and interestingly also increases the Ca
2+ concentration in the
sarcoplasm [19], demonstrating that creatine can slow fatigue.
In fast-twitch muscles (muscles composed primarily of fast-
twitch, or Type 2, fibres), repeated activation depletes stores of
high energy phosphates (ATP and PCr) and there is a graded
failure of Ca
2+ release from the sarcoplasmic reticulum that is
thought to be primarily responsible for the decline in the maximal
force [15]. As mentioned above one mechanism causing this
failure of Ca
2+ release from the SR is the increase of Pi in the
myoplasm (due to the increase in high energy phosphate
utilisation). This Pi enters the SR and precipitates the free calcium
as calcium phosphate [14,15]. A reduction in Pi entering the SR
may explain why fast-twitch muscles of creatine-kinase-deficient
mice (all isoforms) are markedly more fatigue resistant than wild-
types [20].
Creatine has also been reported to increase the Ca
2+ sensitivity
of the contractile proteins, by virtue of the reduction in ionic
strength that occurs when water follows creatine osmotically into
the muscle fibre [21]. The ability to produce more force for a
given intracellular [Ca
2+] would enhance muscle performance and
alleviate some of the force loss resulting from reduced SR Ca
2+
release during fatigue.
Despite some of the abovementioned benefits of creatine for
muscle performance, several studies [22–25] have reported that
oral creatine supplementation has no effect on either twitch or
tetanic force in rodent muscles. As these studies used unpaired
data sets they would not pick up small changes [21]. In addition
they did not examine the effects of creatine supplementation on
fatigued muscles. In a recent study, Bassit et al. [26] showed that in
fatigued muscle the fall in twitch force was less pronounced in the
creatine-supplemented group. Resistance to fatigue during 60 min
of contractile activity was significantly greater in the creatine-
supplemented group as compared to placebo.
The aim of our present study was to provide further insight into
how creatine may enhance muscle performance, by examining the
contractile properties of isolated whole muscles before and after
the acute application of creatine, in the absence and presence of
fatigue. We used an isolated fast-twitch muscle preparation, using
the extensor digitorum longus (EDL) muscle from the mouse
(composed almost entirely of fast glycolytic and fast oxidative fibres
[27]), to examine the rate and extent of the force loss during
muscle fatigue before and after incubating the muscle in creatine.
In each case the muscle was used as its own control, with the
muscle being fatigued in the absence of creatine, allowed to
recover, then incubated in creatine, washed, and subjected again
to the same fatigue protocol. This use of paired data [21] means
that the statistics are very robust in being able to detect small
differences as the same muscle is used for both treatment and
control conditions; additionally, the topical application of creatine




Ethical approval was granted by the Animal Ethics Committee
of the University of New South Wales (AEC 94\025). 12 mice
(C57BL/10) aged 13 to 14 weeks were used. Animals were
sacrificed using an overdose of Halothane (Fluothane
TM, Zeneca
Limited, UK) followed by cervical dislocation.
Water accumulation
In order to assess the water accumulation that resulted from
incubation with 10 mM creatine, 7 EDL muscles were dissected
out, blotted and weighed, then incubated in oxygenated Krebs
solution containing 10 mM creatine for 30 minutes. They were
then blotted on filter paper and weighed again. To see whether
creatine incubation affects the diameter of muscle fibres, single
enzymatically isolated flexor digitorum brevis (FDB) fibres were
viewed under a Nikon inverted microscope at 6600, while
perfused with oxygenated Krebs solution. A graticule was used to
measure the fibre diameter at its widest point. The solution was
then switched to one containing 10 mM creatine for 30 minutes,
after which the fibres were observed during a washout period for
30 minutes. The isolated fibres were firmly attached to the glass
coverslip and the graticule position was monitored throughout the
procedure to ensure that its position relative to the fibre did not
change during the procedure.
Whole muscle setup and solutions
Details of the muscle set-up procedure have been reported
elsewhere [28]. Briefly, the EDL muscles were removed and
attached to a force transducer and positioned between two
platinum plates so that the muscle could be stimulated electrically
and the resultant force response recorded. The muscles were set to
their optimal length and were continuously superfused with Krebs
solution (in mM): 4.75 KCl, 118 NaCl, 1.18 KH2PO4, 1.18
MgSO4, 24.8 NaHCO3, 2.5 CaCl2, 11 glucose, bubbled with 95%
O2 5% CO2 to maintain the pH at 7.4. The optimal length was
termed L0 and all subsequent measures were made at this muscle
length. After determining the set length of the muscle it was
allowed to equilibrate for 5 minutes in the bath.
Following this a force-frequency curve was generated using
frequencies of 2, 5, 10, 15, 20, 25, 30, 50, 60, 75 and 100 Hz. This
served as the ‘‘pre-fatigue’’ force-frequency curve for the muscle. A
fatigue run was then carried out using our published fatigue
protocol [29,30], stimulating the muscle at 100 Hz, 1 second on,
1 second off for 30 seconds. This protocol typically reduced the
force by 70–80%. Immediately following this, a force-frequency
curve was generated to measure the extent and nature of fatigue.
This served as the ‘‘fatigue’’ force-frequency curve. A 20-minute
recovery period followed in which the muscle was stimulated for
200 msec at 100 Hz once every 5 minutes in order to monitor the
rate of recovery from fatigue. A force-frequency curve was then
generated to determine recovery. This served as the ‘‘recovery’’
force-frequency curve. In our laboratory, we have observed that
EDL muscles can be run up to five times through the protocol
described above, without any significant deterioration of the
muscle (unpublished data).
Following determination of the force-frequency characteristics
of untreated muscle (the control condition), the muscle was
incubated in a 9.9 mM creatine solution, prepared by dissolving
creatine (Creatine Anhydrous from SIGMA) in the Krebs solution
described above. The incubation period was 30 minutes and the
muscle was stimulated at 100 Hz for 200 msec once every five
minutes. The creatine-specific transporter protein CreaT [31]
controls cellular creatine uptake. This moves creatine into the cell,
against a concentration gradient, in a sodium- and chloride-
dependent process [31]. Stimulating the muscle throughout
incubation facilitates this uptake as described by Odoom et al.
[32]. The rate of creatine uptake into the muscle under these
conditions is estimated to be 70 nmol gww
21 [4]. The solution
containing creatine was then washed out over a 5-min period and
the muscle re-perfused with Krebs solution, so that the force
produced by the muscle was not secondarily affected by having
Creatine Improves Contractile Function in Fatigue
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procedures. The protocol from the pre-fatigue force-frequency
curve to the post-fatigue force-frequency curve was then repeated.
All experiments were undertaken at 22uC.
In the presentation of results, all forces are expressed as specific
force (absolute force divided by cross-sectional area). The mean
cross-sectional area of each muscle was calculated by dividing the
muscle’s wet mass by the product of its optimum length and the
density of mammalian skeletal muscle (1.06 g cm
23). The wet
muscle mass was measured at the end of each experiment and
hence represents the muscle mass following creatine incubation. In
the water accumulation experiments described above, it was found
that creatine incubation resulted in an average 7.3% increase in
muscle weight. To allow for this, cross-sectional areas have been
reduced by this amount in calculating specific forces before
creatine incubation.
Statistical tests and analysis
A two-tailed paired t-test (GraphPad Prism) was used to test the
significance of treatments. The significance level was P,0.05.
However, when comparing control force versus creatine-treated
force at each stimulation frequency of the force-frequency curve, a
different test was used to reduce the possibility of Type I error
arising from the large number of comparisons. Here we used
Bonferroni multiple comparison post-tests following two-way
repeated measures ANOVA, with an overall significance level of
5% (GraphPad Prism).
One further analysis performed on the force-frequency data was
to fit a sigmoidal curve to the forces measured in every force-
frequency activation sequence. This curve relates the muscle force








where Pmax is the maximum force, Pmin is the minimum force, Kf is
the half-frequency (the frequency at which force is halfway
between minimum and maximum) and h is the Hill coefficient (an
indication of the steepness of the curve).
Results
Whole muscle mass and single fibre diameter in 10 mM
creatine
Creatine enters skeletal muscle by a saturable process, with an
accompanyingincreaseinintracellularwaterthat isevidencedbyan
increase in muscle weight [34]. To show that our incubation
procedure results in the successful uptake of creatine, we incubated
EDL muscles and FDB fibres for 30 minutes in oxygenated Krebs
solution containing 10 mM creatine, and measured resulting
changes in muscle weight and fibre diameter. Following incubation,
there was an increase in EDL wet weight of 7% (Fig. 1A), and an
increase in FDB fibre diameter of 9% (Fig. 1B). These results
demonstrate that our incubation procedure results in the uptake of
creatine by the muscles and by the individual fibres [34].
Force-frequency curves from EDL muscles
The effects of creatine incubation on the force-frequency curves
are illustrated in Fig. 2. Before fatigue (Fig. 2A), creatine treatment
resulted in a significantly higher force at 100 Hz. In fatigued
muscle (Fig. 2B), incubation in a creatine load solution prevented a
significant amount of the loss of force seen as a result of repetitive
activation in the same muscle under control (untreated) conditions.
In the fatigued state, the creatine-treated muscle was found to
produce significantly more force at all frequencies when compared
with the muscle before creatine incubation (Fig. 2B). Maximal
tetanic force in fatigued muscle was 27.061.85 N cm
22 following
creatine incubation compared with 14.962.13 N cm
22 before
creatine treatment (Fig. 2B). After recovery from fatigue (Fig. 2C),
creatine treatment did not significantly affect the force at any
frequency when compared with control.
Sigmoidal curves werefitted to the force-frequency data to obtain
the half-frequency (the frequency at which force is halfway between
minimum and maximum) and the Hill coefficient (a measure of the
steepness of the curve). The values of these parameters are shown in
Fig. 3. When the muscle was fatigued, creatine incubation resulted
in a significant reduction of the half-frequency (Fig. 3A). In terms of
the force-frequency curves for fatigued muscle shown in Fig. 2B, the
curve for creatine-treated muscle has shifted to the left by 10.2 Hz
compared to the control curve. No significant differences in the Hill
coefficient (steepness of the curve) were found between creatine-
treated and control conditions (Fig. 3B).
Twitch and tetanus in EDL muscles
The rate of relaxation during a muscle twitch, calculated as the
fall in force divided by the change in time during the first 50% of
Figure 1. Changes in EDL muscle mass and FDB fibre diameter
following creatine incubation. Creatine incubation resulted in a
significant increase in the wet weight of whole EDL muscle (A) and a
significant increase in the diameter of single FDB fibres (B),
demonstrating the uptake of creatine by these muscles and fibres.
Statistically significant differences are indicated by ‘‘*’’ (P,0.05).
doi:10.1371/journal.pone.0022742.g001
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relaxation following creatine incubation was significantly faster
than control. The rate of contraction during a muscle twitch,
calculated as the peak twitch force divided by the time taken to
reach peak force, is shown in Fig. 4B. In fatigue, the rate of
contraction following creatine incubation was significantly faster
than control.
The twitch-to-tetanus ratio was unchanged for the creatine-
treated condition with respect to the control condition both before
fatigue and after recovery. In creatine-treated muscles, however,
there was a difference between the ratio in fatigue and the ratios
for the pre-fatigue and recovered states. Notably this difference did
not occur before creatine treatment. Fig. 5A shows that creatine
treatment leads to a comparatively greater increase in twitch to
tetanus ratio when the EDL muscles are fatigued compared to
controls.
Fig. 5B shows that creatine treatment increases twitch and
tetanic force when the muscle is fatigued, but has little effect on
twitch and tetanic force when the muscle is recovered.
Rate of fatigue in EDL muscles
Creatine significantly increased the EDL muscle’s resistance to
fatigue. The parameter measured during the fatigue runs was the
time taken for the maximum force produced by the muscle to fall
to 50% of the pre-fatigue maximum. Creatine-treated muscle took
55.169.5% (P,0.05) longer than the control for the force to fall to
this point (Fig. 6A). Total force decline, as a percentage of initial
force, was 84.862.0% before creatine incubation and 71.161.8%
after creatine incubation (P,0.05). Fig. 6B shows the pattern of
force decline during the fatigue run, before and after creatine
incubation.
Discussion
Creatine and its effects on ionic strength and force
production
In the present study we have shown that acute application of
creatine enhances force production in isolated fast-twitch EDL
muscle, especially during fatigue. In unfatigued muscle, creatine
enhanced maximum force production (Fig. 2A). In fatigued
muscle, creatine reduced the half-frequency (Fig. 3A), resulting
in a left-shifting of the force-frequency relationship and an
enhanced force production at every stimulation frequency (Fig. 2B).
We have also shown that acute incubation with creatine
increased the weight of intact muscles and increased the diameter
of individual fibres (Fig. 1). The most likely mechanism for this is
that the uptake of creatine is accompanied by an increase in
cellular water which occurs to maintain osmotic balance [35].
Increases in muscle mass along with water retention have
frequently been reported as a side effect of creatine ingestion.
Studies [36–38] reported increases in fat-free body mass of 1–2 kg
which equates with a 7% increase in muscle water in an average
human [21]. This is consistent with the 7% increase we observed
in the mass of whole muscles following creatine incubation
(Fig. 1A).
Our observed effects of creatine on force and muscle mass are
consistent with the study of Murphy et al. [21], who found that
increased creatine concentration, accompanied by a reduction in
ionic strength mimicking the osmotic uptake of water, enhanced
the Ca
2+ sensitivity and maximum Ca
2+-activated force in
Figure 2. Force-frequency curves for EDL muscles before and
after creatine treatment. Each graph shows the force-frequency
curves under control and creatine-treated conditions. In the pre-fatigue
state (A), creatine significantly increased the force produced at 100 Hz.
In the fatigued state (B), creatine incubation significantly increased the
force produced at every frequency. In the recovered state (C), creatine
had no significant effect on the force at any frequency. Statistically
significant differences are indicated by ‘‘*’’ (P,0.05). Tests for
significance at each frequency were conducted using Bonferroni
multiple comparison post-tests following two-way repeated measures
ANOVA (GraphPad Prism).
doi:10.1371/journal.pone.0022742.g002
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force-pCa curve for EDL fibres was shifted to the left [21], which
is analogous to the left-shifting of the force-frequency curve caused
by creatine in our fatigued muscles. Hence an increase in the Ca
2+
sensitivity of the contractile proteins could underlie the shift of the
force-frequency curve that we found when creatine was applied to
fatigued muscle.
Murphy et al. [21] concluded that the beneficial effects of
creatine occurred through the reduction in ionic strength, rather
than some direct action of creatine, because creatine actually had
an inhibitory effect on force and Ca
2+ sensitivity when ionic
strength was left unchanged. In our present study, we can assume
that the ionic strength within our EDL muscles has decreased,
since the increase in mass following creatine incubation suggests
osmotic water uptake. Hence we postulate that a reduction in ionic
strength following creatine incubation is responsible for the
enhanced force production of our creatine-treated muscles. The
influence of ionic strength on muscle contractility is an established
observation in the literature [39–41]; it is possible that a reduction
in ionic strength enhances the force production and Ca
2+
sensitivity of the contractile apparatus because of reduced
competition from monovalent cations such as K
+ and Na
+ for
binding sites on the thin-filament regulatory proteins [41].
Creatine and fatiguing stimulation
Fatigue can be defined as the inability of a muscle to maintain
maximal force production as a result of repeated activity. Failure
of Ca
2+ release from the SR is considered to be a major cause of
fatigue [42,43]. Fatigued muscle also suffers in respect of
contractile kinetics and there is a slowing of contraction and
relaxation. Using the alteration of these parameters as a measure
of fatigue a major finding of this study was that incubation in a
creatine solution, followed by a wash before initiating the fatigue
protocol, caused an improved resistance to fatigue in mouse fast-
twitch EDL muscle (Fig. 6).
Why does creatine have this inhibitory effect on fatigue? One
mechanism that can be deduced from earlier studies is that
creatine helps to maintain Ca
2+ release during fatigue. When
creatine is transported into the muscle fibre a proportion of it will
be phosphorylated and become part of the phosphocreatine cycle
[44]. The Cr/PCr cycle is the major provider of ATP during
intense activity in skeletal muscle. The failure of Ca
2+ release is
thought to be primarily due to the build up of Pi which occurs due
to the high rates of ATP hydrolysis during intense muscle
activation. This Pi enters the SR via an ATP-dependent ion
channel transport mechanism (the channel is activated by low
Figure 4. Twitch kinetics of EDL muscles before and after
creatine treatment. A, Rate of relaxation. Creatine treatment resulted
in significantly faster relaxation in fatigued muscle. B,R a t eo f
contraction. Creatine treatment resulted in significantly faster contrac-
tion in fatigued muscle. Statistically significant differences are indicated
by ‘‘*’’ (P,0.05).
doi:10.1371/journal.pone.0022742.g004 Figure 3. Half-frequency and Hill coefficient of force-frequency
curves. Sigmoidal curves were fitted to the force-frequency data to
obtain the half-frequency (A) and Hill coefficient (B). Creatine treatment
resulted in a significant reduction in the half-frequency in fatigued
muscle. Statistically significant differences are indicated by ‘‘*’’ (P,0.05).
doi:10.1371/journal.pone.0022742.g003
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2+ resulting in a failure of
Ca
2+ release [42]. Thus increased levels of PCr will keep the Pi
levels lower by using the free inorganic phosphate to regenerate
ATP from ADP. In addition the open probability of the phosphate
transporter in the SR will be reduced as ATP levels are higher.
Supporting this, Gallo et al. [45] noted that high levels of creatine
supplementation which increased intramuscular creatine by 20%
improved fatigue resistance in rat EDL muscle by 20% and 7%
after 10 and 30 s of stimulation, respectively.
However, another mechanism has been proposed where force is
enhanced due to the increased Ca
2+ sensitivity of the contractile
proteins arising from the reduction in ionic strength that
accompanies Cr loading [21]. This is a likely mechanism in our
current study, given the left-shifting of the force-frequency curve in
fatigue following creatine incubation. Thus even if Ca
2+ release
from the SR was impaired during fatigue, creatine incubation may
attenuate the resulting loss of force by making the contractile
proteins more sensitive to Ca
2+.
Creatine and its effect on twitch kinetics
The slowing of contractile kinetics during fatigue is a well
established finding in the literature. The decreased speed of
relaxation [46] and contraction [47] becomes progressively more
pronounced throughout a fatiguing protocol. Relaxation processes
account for an important fraction of total energy consumption in
muscles during short repeated contractions [48,49]. Relaxation is a
Figure 5. Twitch and tetanus in EDL muscles before and after creatine treatment. A, twitch to tetanus ratios expressed relative to the pre-
fatigue twitch to tetanus ratio. Before creatine incubation, the twitch to tetanus ratio in fatigued muscle was similar to that in the pre-fatigue state.
After creatine incubation however, the twitch to tetanus ratio in the fatigued state was significantly higher than in the pre-fatigue state. Statistically
significant differences are indicated by ‘‘*’’ (P,0.05). B, force tracings of twitches and 100-Hz tetani obtained from one EDL muscle. In the fatigued
muscle, creatine incubation increases the twitch force and tetanic force. In the recovered muscle however, creatine incubation makes little difference
to the twitch and tetanic forces.
doi:10.1371/journal.pone.0022742.g005
Figure 6. Fatigue run in EDL muscles before and after creatine treatment. A, time taken for force to fall to 50% of original force. Creatine
incubation resulted in a significant increase in this parameter. B, pattern of force decline during the fatigue run, showing the effect of creatine
treatment in improving the resistance of muscles to fatigue. It is evident that creatine incubation is associated with an increase in the time taken for
force to fall to 50%, as well as a reduction in the total force decline over the whole fatigue run. Statistically significant differences are indicated by ‘‘*’’
(P,0.05).
doi:10.1371/journal.pone.0022742.g006
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changes to the relaxation process have been used. In a review by
Gillis [50], relaxation is described as having two distinct phases.
The first is the plateau which is a slow linear decline in tension
with no change in muscle length. During this phase the
intracellular [Ca
2+] falls rapidly [51]. In the second phase tension
drops rapidly with Ca
2+ levels relatively constant [51]. Creatine
supplementation has been shown to decrease half relaxation time
[52] and to improve Ca
2+ handling in dystrophic muscle [31]. The
creatine analogue b-GPA (b-Guanidinopropionoic acid) depletes
cellular creatine (and hence phosophocreatine levels) and causes
an increase in time to half relaxation [53]. In the absence of the
phosphocreatine buffering system (achieved by inhibiting creatine
kinase using dinitroflourobenzene) shortening velocity can be up to
30% slower than the control both in mouse skeletal muscle [47]
and in frog skeletal muscle [54]. Conversely, mice genetically
modified to have an increased expression of creatine kinase
demonstrated a faster shortening velocity during a 5 second
tetanus [55]. Steeghs et al. [56] found that CK-deficient muscle
tested in vivo displayed an impaired peak tetanic force, a reduced
ability to sustain maximal contractions and an increased time to
half relaxation. Further, in myotube cultures from the same strain
of mouse, both the release and sequestration of Ca
2+ were
negatively affected as measured by a reduced peak and an
extended duration of the Ca
2+ released in a twitch.
In the present study it is possible that the increased rates of
contraction and relaxation seen in fatigued muscle pre-incubated
in creatine (Fig. 4) is a consequence of lowered ionic strength.
However, we cannot rule out an increased supply of PCr as a
result of creatine uptake in improving the contractile kinetics. In
humans, creatine supplementation increased intramuscular crea-
tine by 8% and significantly improved performance during the
transition from rest to both moderate- and heavy-intensity
exercise, and also improved performance in the transition from
moderate-intensity exercise to rest [57].
Conclusions
We have shown that acute incubation with creatine enhances
force production in fast-twitch EDL muscle, especially when the
muscle is fatigued. Such an effect is likely to occur through an
increased Ca
2+ sensitivity of the contractile proteins due to the
reduction in ionic strength that accompanies creatine incubation.
The improved resistance to loss of force during fatiguing
stimulation is also likely to be explained by an increased Ca
2+
sensitivity. We have also shown that in fatigued muscle, creatine
incubation increases the rate of twitch contraction and relaxation.
In fatigued muscle, even small changes in force production and
contractile kinetics could be very important in terms of human
performance in a race situation. Thus the effects of creatine
incubation on isolated muscle demonstrated in our study provide
insight into the improved muscle performance observed following
creatine supplementation in humans. Providing there are no as yet
undiscovered health risks associated with creatine supplementa-
tion, creatine may be of great benefit both to athletes and as a
therapeutic tool for the treatment of neuromuscular disorders.
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